Covered recipient · General Payments record
ERIKA G GONZALEZ
Allopathic & Osteopathic Physicians Allergy & Immunology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2023 · Entire year
$9,833.06
114 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2023 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,600.00 | 1 |
| Food and Beverage | $2,576.86 | 106 |
| Travel and Lodging | $1,599.20 | 6 |
| Education | $57.00 | 1 |
By paying entity
PY2023 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca UK Limited | $6,920.47 | 8 |
| GENZYME CORPORATION | $629.91 | 14 |
| Regeneron Healthcare Solutions, Inc. | $440.19 | 13 |
| Medtronic, Inc. | $411.34 | 1 |
| GlaxoSmithKline, LLC. | $278.43 | 19 |
| AstraZeneca Pharmaceuticals LP | $241.24 | 11 |
| Genentech USA, Inc. | $240.28 | 13 |
| SANOFI-AVENTIS U.S. LLC | $216.05 | 12 |
| Novartis Pharmaceuticals Corporation | $113.27 | 5 |
| kaleo, Inc. | $80.29 | 4 |
| Octapharma USA, Inc. | $40.00 | 2 |
| Amgen Inc. | $39.11 | 2 |
| Grifols USA, LLC | $37.19 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.90 | 1 |
| ALK-Abello, Inc | $22.61 | 1 |
| Regeneron Pharmaceuticals, Inc. | $21.33 | 1 |
| CSL Behring | $19.14 | 1 |
| Pharming Healthcare, Inc. | $16.15 | 1 |
| Merck Sharp & Dohme LLC | $14.25 | 1 |
| Incyte Corporation | $14.20 | 1 |
| Blueprint Medicines Corporation | $13.71 | 1 |
Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
ERIKA G GONZALEZ
NPI 1427022516 · CMS profile ID 337313
Allopathic & Osteopathic Physicians / Allergy & Immunology
SAN ANTONIO, TX
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- ERIKA G GONZALEZ, NPI 1427022516, CMS profile ID 337313. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- APA 7
- IndustryPayments. (2026). ERIKA G GONZALEZ, NPI 1427022516, CMS profile ID 337313. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- Bluebook
- ERIKA G GONZALEZ, NPI 1427022516, CMS profile ID 337313, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2023
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30
114 matching records · $9,833.06 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 114.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Genentech USA, Inc. | $2.68 | 05/30/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040360189 | CMS |
| Blueprint Medicines Corporation | $13.71 | 05/26/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1051273967 | CMS |
| GENZYME CORPORATION | $119.11 | 05/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039215 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.67 | 05/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999190943 | CMS |
| Octapharma USA, Inc. | $20.00 | 05/18/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1042723783 | CMS |
| Amgen Inc. | $18.93 | 05/17/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1019905717 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.69 | 05/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999190939 | CMS |
| GENZYME CORPORATION | $25.61 | 05/05/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039235 | CMS |
| GlaxoSmithKline, LLC. | $30.38 | 05/02/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001544435 | CMS |
| GlaxoSmithKline, LLC. | $11.47 | 04/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001545059 | CMS |
| kaleo, Inc. | $15.48 | 04/17/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1013029069 | CMS |
| Novartis Pharmaceuticals Corporation | $17.00 | 04/10/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 991986375 | CMS |
| GlaxoSmithKline, LLC. | $10.44 | 04/06/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001544475 | CMS |
| GlaxoSmithKline, LLC. | $14.49 | 04/05/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001542407 | CMS |
| Incyte Corporation | $14.20 | 04/05/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1044170743 | CMS |
| GlaxoSmithKline, LLC. | $15.83 | 03/29/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001543859 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.15 | 03/29/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999190935 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.10 | 03/28/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039171 | CMS |
| GENZYME CORPORATION | $34.70 | 03/27/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039175 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.83 | 03/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999190931 | CMS |
| Regeneron Pharmaceuticals, Inc. | $21.33 | 03/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1000013051 | CMS |
| SANOFI-AVENTIS U.S. LLC | $11.28 | 03/22/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039167 | CMS |
| Novartis Pharmaceuticals Corporation | $19.32 | 03/21/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 991986371 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.24 | 03/21/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039163 | CMS |
| AstraZeneca UK Limited | $48.65 | 03/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016984019 | CMS |
| AstraZeneca UK Limited | $54.85 | 03/20/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017022993 | CMS |
| GENZYME CORPORATION | $15.06 | 03/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039179 | CMS |
| Grifols USA, LLC | $17.68 | 03/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1011873639 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.32 | 03/16/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1015344893 | CMS |
| Genentech USA, Inc. | $15.61 | 03/07/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040360161 | CMS |
| Novartis Pharmaceuticals Corporation | $16.38 | 03/06/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 991986367 | CMS |
| ALK-Abello, Inc | $22.61 | 03/04/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017126085 | CMS |
| AstraZeneca UK Limited | $645.40 | 03/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016997471 | CMS |
| AstraZeneca UK Limited | $116.67 | 03/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017018127 | CMS |
| AstraZeneca UK Limited | $83.96 | 03/03/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017019267 | CMS |
| AstraZeneca UK Limited | $145.00 | 03/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017026201 | CMS |
| AstraZeneca UK Limited | $225.94 | 03/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017061561 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.20 | 03/02/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016268423 | CMS |
| AstraZeneca Pharmaceuticals LP | $36.36 | 02/25/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1015799731 | CMS |
| GENZYME CORPORATION | $52.07 | 02/25/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039127 | CMS |
| GlaxoSmithKline, LLC. | $57.00 | 02/25/2023 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1061464697 | CMS |
| GENZYME CORPORATION | $34.19 | 02/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039145 | CMS |
| Genentech USA, Inc. | $8.13 | 02/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040360165 | CMS |
| Novartis Pharmaceuticals Corporation | $43.09 | 02/24/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 991986351 | CMS |
| kaleo, Inc. | $17.42 | 02/22/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1013029061 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.00 | 02/21/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1014531247 | CMS |
| GlaxoSmithKline, LLC. | $4.12 | 02/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001543001 | CMS |
| GlaxoSmithKline, LLC. | $11.08 | 02/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1001545163 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.37 | 02/14/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999190927 | CMS |
| SANOFI-AVENTIS U.S. LLC | $27.52 | 02/13/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1050039119 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $365,230.57 | 522 |
| PY2024 | Principal investigator | $249,852.55 | 169 |
| PY2023 | Principal investigator | $219,935.68 | 171 |
| PY2022 | Principal investigator | $302,366.57 | 72 |
| PY2021 | Principal investigator | $357,558.38 | 45 |
| PY2020 | Principal investigator | $396,007.51 | 42 |
| PY2019 | Recipient | $1,667.94 | 5 |
| PY2019 | Principal investigator | $240,846.48 | 34 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
522 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $500.00 | 12/24/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184280236 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $1,000.00 | 12/24/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184280238 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $1,000.00 | 12/24/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184280240 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $2,544.72 | 12/11/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244045884 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $1,365.00 | 11/26/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184265429 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $150.00 | 11/26/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184265431 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $150.00 | 11/26/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184265433 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $150.00 | 11/26/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184265435 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $13,645.44 | 11/20/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046102 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $3,000.00 | 11/13/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046100 |
| Principal investigator 1 | Novartis Pharmaceuticals Corporation | $315.71 | 11/10/2025 | Non-covered Recipient Entity SYLVANA RESEARCH ASSOCIATES | A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately co | No dispute reported | 06/30/2026 | 1190298719 |
| Principal investigator 1 | Amgen Inc. | $3,500.00 | 10/24/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma | No dispute reported | 06/30/2026 | 1246648661 |
| Principal investigator 1 | AstraZeneca UK Limited | $9,000.00 | 10/16/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | Multicentre,Randomised,Double blind,Parallel Group,Placebo controlled,Time to first Asthma Exacerbation Phase tree Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eosinophilic Asthma Dominika | No dispute reported | 06/30/2026 | 1185549261 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $1,000.00 | 10/09/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046096 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $5,456.00 | 10/09/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046098 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 10/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184246560 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 10/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184246562 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $3,964.86 | 09/25/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046094 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $7,200.00 | 09/19/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK | A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect and Safety of PT007 AS MDI to Placebo MDI and Open-Label Ventolin Evohaler in Adult Participants with Asthma MITCHELL | No dispute reported | 06/30/2026 | 1185549263 |
| Principal investigator 1 | AstraZeneca UK Limited | $26,500.00 | 09/12/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | BRISOTE A Multicentre Randomised DoubleBlind Parallel Group ActiveControlled Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium Dose Inhaled Corticosteroid Plus Long acting 2 Agonist | No dispute reported | 06/30/2026 | 1185549259 |
| Principal investigator 1 | Optinose US, Inc. | $6,500.00 | 09/05/2025 | Non-covered Recipient Entity Midwest Allergy Sinus Asthma, SC | A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps | No dispute reported | 06/30/2026 | 1163251989 |
| Principal investigator 1 | Novartis Pharmaceuticals Corporation | $63,730.60 | 09/01/2025 | Non-covered Recipient Entity SYLVANA RESEARCH ASSOCIATES | A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately co | No dispute reported | 06/30/2026 | 1190298724 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $9,944.28 | 08/21/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046092 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $15,946.59 | 06/24/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046298 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $274.95 | 06/18/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184207681 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $274.95 | 06/18/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184207683 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 06/18/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184207971 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 06/18/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184207973 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 06/18/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184207975 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $1,813.06 | 05/08/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046296 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 05/07/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184193415 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 05/07/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184193417 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 05/07/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184193419 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 05/07/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184193421 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 05/07/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184193423 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $37,930.80 | 05/01/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | a randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with asthma ACADIA | No dispute reported | 06/30/2026 | 1185549257 |
| Principal investigator 1 | AstraZeneca UK Limited | $34,921.30 | 04/28/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK | a randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with asthma ACADIA | No dispute reported | 06/30/2026 | 1185549253 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $468.39 | 04/28/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184190509 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $468.39 | 04/28/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184190511 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $468.39 | 04/28/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184190513 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $468.39 | 04/28/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184190515 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $796.05 | 04/02/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT | No dispute reported | 06/30/2026 | 1192145431 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $204.60 | 03/03/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046002 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 02/27/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184155826 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $274.95 | 02/27/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184155828 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $9,927.71 | 02/26/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT | No dispute reported | 06/30/2026 | 1192142818 |
| Principal investigator 1 | Amgen Inc. | $1,869.52 | 02/25/2025 | Non-covered Recipient Entity SOUTH TEXAS ALLERGY AND ASTHMA MEDICAL PROFESSIONALS | A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma | No dispute reported | 06/30/2026 | 1246648379 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $5,075.81 | 02/24/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod | No dispute reported | 06/30/2026 | 1185549265 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $10,480.54 | 02/13/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046294 |
| Principal investigator 1 | SANOFI US SERVICES INC. | $17,200.00 | 02/12/2025 | Non-covered Recipient Entity Staamp Research Llc | ACT - POC clinical study - IL13 x TSLP Nanobody VHH - lunsekimig | No dispute reported | 06/30/2026 | 1226103666 |
| Principal investigator 1 | GlaxoSmithKline, LLC. | $1,723.20 | 02/07/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT | No dispute reported | 06/30/2026 | 1192142811 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151863 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151865 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151869 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151871 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151873 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151875 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151877 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151879 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151881 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151883 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151885 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151887 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151891 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151893 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151895 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $80.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151897 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151899 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $45.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151901 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151903 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $28.60 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151905 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151907 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $33.80 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151909 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151913 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $62.40 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151915 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151917 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151919 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $33.80 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151921 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151923 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151925 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151927 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151929 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151931 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151935 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $50.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151937 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151939 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151941 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $45.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151943 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $26.00 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151945 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151947 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151949 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151951 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $28.60 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151953 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151957 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151959 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $28.60 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151961 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151963 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $45.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151965 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151967 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151969 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151971 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151973 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151975 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $28.60 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151979 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $50.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151981 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151983 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $45.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151985 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $50.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151987 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $33.80 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151989 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151991 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $28.60 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151993 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151995 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $45.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184151997 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152001 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152003 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $45.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152005 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152007 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $62.40 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152009 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152011 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $50.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152013 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $28.60 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152015 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $35.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152017 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $37.70 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152019 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $165.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152023 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $33.80 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152025 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $4,338.10 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152027 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $62.40 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152029 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152031 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152033 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $754.65 | 02/05/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | No dispute reported | 06/30/2026 | 1184152035 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $2,535.00 | 01/20/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184148874 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $9,500.00 | 01/20/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184148876 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $974.00 | 01/20/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA | No dispute reported | 06/30/2026 | 1184148878 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $68.20 | 01/13/2025 | Non-covered Recipient Entity CRN CLINICAL RESEARCH NETWORK LLC | A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma | No dispute reported | 06/30/2026 | 1244046000 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $14,130.89 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler | No dispute reported | 06/30/2026 | 1185549255 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144852 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144854 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144856 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144858 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144860 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144862 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144864 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144866 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144868 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144870 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144872 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144874 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144876 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144878 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144880 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144882 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144884 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144886 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144888 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144890 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144892 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144894 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144896 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144898 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144900 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144902 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144904 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144906 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144908 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144910 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144912 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144914 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144916 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144918 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144920 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144922 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144924 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144926 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144928 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144930 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144932 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144934 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144936 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144938 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144940 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144942 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144944 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144946 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144948 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144950 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144952 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144954 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144956 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144958 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144960 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144962 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144964 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144966 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144968 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144970 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144972 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144974 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144976 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144978 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144980 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144982 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144984 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144986 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144988 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144990 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144992 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144994 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144996 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184144998 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145000 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145002 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145004 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145006 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145008 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145010 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145012 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145014 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145016 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145018 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145020 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145022 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145024 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145026 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145028 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145030 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145032 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145034 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145036 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145038 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145040 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145042 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145044 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145046 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145048 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145050 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145052 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145054 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145056 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145058 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145060 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145062 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145064 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145066 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145068 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145070 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145072 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145074 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145076 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145078 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145080 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145082 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145084 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145086 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145088 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145090 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145092 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145094 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145096 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145098 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145100 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145102 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145104 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145106 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145108 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145110 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145112 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145114 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145116 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145118 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145120 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145122 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145124 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145126 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145128 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145130 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145132 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145134 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145136 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145138 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145140 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145142 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145144 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145146 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145148 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145150 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145152 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145154 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145156 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145158 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145160 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145162 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145164 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145166 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145168 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145170 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145172 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145174 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145176 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145178 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145180 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145182 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145184 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145186 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145188 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145190 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145192 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145194 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145196 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145198 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145200 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145202 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145204 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145206 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145208 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145210 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145212 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145214 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145216 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145218 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145220 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145222 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145224 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145226 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145228 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145230 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145232 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145234 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145236 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145238 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145240 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145242 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145244 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145246 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145248 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145250 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145252 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145254 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145256 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145258 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145260 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145262 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145264 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145266 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145268 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145270 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145272 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145274 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145276 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145278 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145280 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145282 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145284 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145286 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145288 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145290 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145292 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145294 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145296 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145298 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145300 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145302 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145304 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145306 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145308 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145310 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145312 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145314 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145316 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145318 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145320 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145322 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145324 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145326 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145328 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145330 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145332 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145334 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145336 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145338 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145340 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145342 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145344 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145346 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145348 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145350 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145352 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145354 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145356 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145358 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145360 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $26.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145362 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145364 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145366 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145368 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145370 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145372 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145374 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145376 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145378 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145380 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145382 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145384 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145386 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145388 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145390 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145392 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145394 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145396 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145398 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145400 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145402 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145404 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145406 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145408 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145410 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145412 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145414 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145416 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145418 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145420 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145422 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145424 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145426 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145428 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145430 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145432 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145434 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145436 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145438 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145440 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145442 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145444 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145446 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145448 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145450 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145452 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145454 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145456 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145458 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145460 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145462 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145464 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145466 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145468 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145470 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145472 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145474 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145476 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145478 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145480 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145482 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145484 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145486 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145488 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145490 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145492 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145494 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145496 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145498 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145500 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145502 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145504 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145506 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145508 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145510 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145512 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145514 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145516 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145518 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145520 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145522 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145524 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145526 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145528 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145530 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145532 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145534 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145536 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145538 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145540 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145542 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145544 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145546 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145548 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145550 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145552 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145554 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145556 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145558 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145560 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145562 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145564 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145566 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145568 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145570 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145572 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145574 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145576 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145578 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145580 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145582 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145584 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145586 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145588 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145590 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145592 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145594 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145596 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145598 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145600 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145602 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145604 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145606 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145608 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145610 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145612 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $27.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145614 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $20.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145616 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $25.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145618 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $14.00 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145620 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $32.50 | 01/03/2025 | Non-covered Recipient Entity STAAMP RESEARCH LLC | REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | No dispute reported | 06/30/2026 | 1184145622 |
| Principal investigator 1 | Novartis Pharmaceuticals Corporation | $12,361.98 | 01/01/2025 | Non-covered Recipient Entity SYLVANA RESEARCH ASSOCIATES | A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately co | No dispute reported | 06/30/2026 | 1190298727 |